|
Volumn 25, Issue 9, 2013, Pages 436-440
|
The role of everolimus-eluting and resolute zotarolimus-eluting stents in the treatment of coronary bifurcations
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
CLOPIDOGREL;
CREATINE KINASE MB;
ENDEAVOR RESOLUTE;
EVEROLIMUS;
FIBRINOGEN RECEPTOR ANTAGONIST;
HEPARIN;
PROMUS;
PROMUS ELEMENT;
TICLOPIDINE;
UNCLASSIFIED DRUG;
XIENCE PRIME;
ZOTAROLIMUS;
ADULT;
AGED;
ARTICLE;
BLOOD CLOTTING TIME;
CARDIAC PATIENT;
CARDIOVASCULAR MORTALITY;
COMPARATIVE EFFECTIVENESS;
CONTROLLED STUDY;
CORONARY BIFURCATION LESION;
DRUG ELUTING STENT;
FEMALE;
FOLLOW UP;
HEART DISEASE;
HEART INFARCTION;
HEART LEFT VENTRICLE EJECTION FRACTION;
HEART MUSCLE REVASCULARIZATION;
HUMAN;
LOADING DRUG DOSE;
MAJOR CLINICAL STUDY;
MALE;
OUTCOME ASSESSMENT;
PERCUTANEOUS CORONARY INTERVENTION;
RETROSPECTIVE STUDY;
STENT THROMBOSIS;
AGED;
CORONARY ANGIOGRAPHY;
CORONARY ARTERY DISEASE;
CORONARY VESSELS;
DRUG-ELUTING STENTS;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
MALE;
MIDDLE AGED;
PERCUTANEOUS CORONARY INTERVENTION;
RETROSPECTIVE STUDIES;
SIROLIMUS;
TREATMENT OUTCOME;
|
EID: 84883595365
PISSN: 10423931
EISSN: 15572501
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (7)
|
References (0)
|